← brief for 2026-08-27 · Slowing decline

Reconsidering the Association Between GLP-1 Receptor Agonists and Atrial Fibrillation Risk in Chronic Kidney Disease.

Article No results yet Peer reviewed

Key takeaways

This is a commentary, not a study. It re-examines earlier reports that tied GLP-1 drugs, the diabetes and weight loss medicines, to atrial fibrillation, an irregular heartbeat, in people with chronic kidney disease. The authors argue the reported link is weaker than it first appeared. No new patient data is presented, so nothing here changes what is known yet.

Who did this work

Chen W · Wang X · Xiao Y

Source

Article · PubMed, the drug frontier · 2026 Aug 27
https://pubmed.ncbi.nlm.nih.gov/42658385/